Printer Friendly

GLOBAL GREEN PETITIONS SEC STOCK SUSPENSION.

Global Green, Inc. has retained Snyderburn, Rishoi & Swann LLP, a law firm that will handle the petition to be filed with the Securities and Exchange Commission to challenge the Commission's Order that suspended trading in the stock of Global Green, Inc. shares in the OTC Market.

Further, at this time, Global Green, Inc. is seeking another vaccine manufacturer and evaluating how to proceed with the studies on its patented Salmogenics vaccine. This will take time and negotiations and will put the schedule of the attempt at USDA approval for the vaccine behind by an estimated 18-24 months.

About Global Green, Inc.

Global Green, Inc. is a green bio-pharmaceutical company that identify technology platforms and commercializing vaccines that contain natural organisms that are not genetically modified, utilizing pharmaceutical standards without the use of mercury.

For more information, visit www.globalgreeninc.com or call 727/480-3082.

COPYRIGHT 2014 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Biotech Financial Reports
Date:Nov 1, 2014
Words:144
Previous Article:CONSORT MEDICAL ACQUIRES AESICA PHARMACEUTICALS.
Next Article:FDA CLEARS NEXT-GENERATION SURGIMAP 2.0 SOFTWARE.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters